Skip to main content

Treatment challenges associated with primary extramammary Paget’s disease

Abstract

Extramammary Paget’s disease (EMPD) is a rarely described skin neoplasm primarily affecting the anogenital region. The diagnosis of EMPD is often delayed due to misdiagnosis which results in delayed treatment. Surgical excision is the mainstay of treatment in patients diagnosed with EMPD. However, cancerous remains are relatively often found due to difficulties with defining the tumor margins during surgery. This results in multiple re-excisions and potential dissemination. We here present two cases of primary EMPD in males and challenges associated with EMPD treatment. Mapping biopsies can provide valuable knowledge and prohibit multiple unsuccessful re-excisions, in patients where the tumor border is difficult to define. A mapping strategy can also contribute to a reduced skin excision, which is crucial in the genital region. Furthermore, we find that PET-CT is an important tool in the disease staging and, hence, selection of adequate treatment strategies.

Level of evidence: Level V, therapeutic study.

This is a preview of subscription content, access via your institution.

Fig. 1

Data availability

Not applicable

Code availability

Not applicable

References

  1. 1.

    Crocker HR (1889) Paget’s disease affecting the scrotum and penis. Trans Pathol Soc Lond 40:187–191

    Google Scholar 

  2. 2.

    Siesling S, Elferink MA, van Dijck JA, Pierie JP, Blokx WA (2007) Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol 33(8):951–955. https://doi.org/10.1016/j.ejso.2006.11.028

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Lee KY, Roh MR, Chung WG, Chung KY (2009) Comparison of Mohs micrographic surgery and wide excision for extramammary Paget’s Disease: Korean experience. Dermatol Surg 35(1):34–40. https://doi.org/10.1111/j.1524-4725.2008.34380.x

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Lloyd J, Flanagan AM (2000) Mammary and extramammary Paget’s disease. J Clin Pathol 53(10):742–749. https://doi.org/10.1136/jcp.53.10.742

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Heymann WR (1993) Extramammary Paget’s disease. Clin Dermatol 11(1):83–87. https://doi.org/10.1016/0738-081x(93)90101-h

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Yoshimura K, Fujimoto M (2016) A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci 83(3):234–239. https://doi.org/10.1016/j.jdermsci.2016.06.004

    Article  PubMed  Google Scholar 

  7. 7.

    Kyriazanos ID, Stamos NP, Miliadis L, Noussis G, Stoidis CN (2011) Extra-mammary Paget’s disease of the perianal region: a review of the literature emphasizing the operative management technique. Surg Oncol 20(2):e61-71. https://doi.org/10.1016/j.suronc.2010.09.005

    Article  PubMed  Google Scholar 

  8. 8.

    Li ZG, Qin XJ (2015) Extensive invasive extramammary Paget disease evaluated by F-18 FDG PET/CT: a case report. Medicine (Baltimore) 94(3):e371. https://doi.org/10.1097/MD.0000000000000371

    Article  Google Scholar 

  9. 9.

    Tian Y, Wu HB, Li DL, Li HS, Zhou WL, Wang QS (2015) Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget’s disease. Nucl Med Commun 36(9):892–897. https://doi.org/10.1097/MNM.0000000000000340

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Hendi A, Brodland DG, Zitelli JA (2004) Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 51(5):767–773. https://doi.org/10.1016/j.jaad.2004.07.004

    Article  PubMed  Google Scholar 

  11. 11.

    Lee GC, Kunitake H, Stafford C, Bordeianou LG, Francone TD, Ricciardi R (2019) High risk of proximal and local neoplasms in 2206 patients with anogenital extramammary Paget’s disease. Dis Colon Rectum 62(11):1283–1293. https://doi.org/10.1097/DCR.0000000000001487

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, Yamazaki N (2013) Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol 168(6):1259–1266. https://doi.org/10.1111/bjd.12249

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

Not applicable

Corresponding author

Correspondence to Lars Bjørn Stolle.

Ethics declarations

Ethical approval

The study was in accordance with the 1964 Helsinki Declarations and its later amendments and in line with the specific policies from Aarhus University Hospital. No ethical approval was required for this case report.

Consent to participate

Informed consent was secured from both participants, in line with the specific policies from Aarhus University Hospital.

Consent to publish

The authors affirm that patients provided informed consent regarding publishing their data, including the photographies in Fig. 1.

Conflict of interest

Thomas Vestermark Thomsen, Ahmad Makki, Emir Hasanbegovic, Mikkel Børsen Rindom, and Lars Bjørn Stolle declare no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Thomsen, T.V., Makki, A., Hasanbegovic, E. et al. Treatment challenges associated with primary extramammary Paget’s disease. Eur J Plast Surg (2021). https://doi.org/10.1007/s00238-021-01876-4

Download citation

Keywords

  • Extramammary Paget’s disease
  • EMPD
  • Male genitalia
  • Metastasis
  • Mapping biopsies
  • Treatment